1-(beta-mercapto-beta,beta-cyclopentamethylenepropionic acid)-2-(o-ethyl-tyr)-4-val-arginine vasopressin has been researched along with benserazide in 1 studies
*Benserazide: An inhibitor of DOPA DECARBOXYLASE that does not enter the central nervous system. It is often given with LEVODOPA in the treatment of parkinsonism to prevent the conversion of levodopa to dopamine in the periphery, thereby increasing the amount that reaches the central nervous system and reducing the required dose. It has no antiparkinson actions when given alone. [MeSH]
*Benserazide: An inhibitor of DOPA DECARBOXYLASE that does not enter the central nervous system. It is often given with LEVODOPA in the treatment of parkinsonism to prevent the conversion of levodopa to dopamine in the periphery, thereby increasing the amount that reaches the central nervous system and reducing the required dose. It has no antiparkinson actions when given alone. [MeSH]
| Studies (1-(beta-mercapto-beta,beta-cyclopentamethylenepropionic acid)-2-(o-ethyl-tyr)-4-val-arginine vasopressin) | Trials (1-(beta-mercapto-beta,beta-cyclopentamethylenepropionic acid)-2-(o-ethyl-tyr)-4-val-arginine vasopressin) | Recent Studies (post-2010) (1-(beta-mercapto-beta,beta-cyclopentamethylenepropionic acid)-2-(o-ethyl-tyr)-4-val-arginine vasopressin) | Studies (benserazide) | Trials (benserazide) | Recent Studies (post-2010) (benserazide) |
|---|---|---|---|---|---|
| 35 | 0 | 0 | 1,113 | 162 | 156 |
| Protein | Taxonomy | 1-(beta-mercapto-beta,beta-cyclopentamethylenepropionic acid)-2-(o-ethyl-tyr)-4-val-arginine vasopressin (IC50) | benserazide (IC50) |
|---|---|---|---|
| Genome polyprotein | Coxsackievirus B3 (strain Nancy) | 2.4 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 0.14 | |
| Hexokinase-2 | Homo sapiens (human) | 5.52 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, XR; Shi, L; Wang, WH; Yao, T | 1 |
1 other study(ies) available for 1-(beta-mercapto-beta,beta-cyclopentamethylenepropionic acid)-2-(o-ethyl-tyr)-4-val-arginine vasopressin and benserazide
| Article | Year |
|---|---|
[Role of the hypophysis in the renal responses upon stimulation of the brain osmoreceptor].
Topics: Animals; Arginine Vasopressin; Benserazide; Diuresis; Hypophysectomy; Injections, Intraventricular; Male; Natriuresis; Osmolar Concentration; Pituitary Gland; Rats; Rats, Sprague-Dawley; Saline Solution, Hypertonic; Vasopressins; Water-Electrolyte Balance | 1992 |